The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care

OBJECTIVES: Following litigation over pregabalin’s second-use medical patent for neuropathic pain, National Health Service (NHS) England was required by the court to instruct general practitioners (GPs) to prescribe the branded form (Lyrica) for pain. Pfizer’s patent was found invalid in 2015, a rul...

Descripción completa

Detalles Bibliográficos
Autores principales: Croker, Richard, Smyth, Darren, Walker, Alex J, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
General practice / Family practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009558/
https://www.ncbi.nlm.nih.gov/pubmed/29880577
http://dx.doi.org/10.1136/bmjopen-2018-022416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009558/
https://www.ncbi.nlm.nih.gov/pubmed/29880577
http://dx.doi.org/10.1136/bmjopen-2018-022416

Ejemplares similares